Equillium Inc (EQ)
0.6842
-0.10
(-12.33%)
USD |
NASDAQ |
Nov 14, 16:00
0.6704
-0.01
(-2.02%)
After-Hours: 05:21
Equillium Free Cash Flow: -15.77M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -15.77M |
| March 31, 2024 | -22.66M |
| December 31, 2023 | -21.83M |
| September 30, 2023 | 11.59M |
| June 30, 2023 | 0.448M |
| March 31, 2023 | -4.65M |
| December 31, 2022 | -9.012M |
| September 30, 2022 | -46.87M |
| June 30, 2022 | -40.85M |
| March 31, 2022 | -36.55M |
| December 31, 2021 | -32.14M |
| September 30, 2021 | -30.29M |
| Date | Value |
|---|---|
| June 30, 2021 | -28.32M |
| March 31, 2021 | -26.38M |
| December 31, 2020 | -24.83M |
| September 30, 2020 | -25.59M |
| June 30, 2020 | -25.21M |
| March 31, 2020 | -24.93M |
| December 31, 2019 | -23.02M |
| September 30, 2019 | -17.81M |
| June 30, 2019 | -14.76M |
| March 31, 2019 | -11.14M |
| December 31, 2018 | -7.561M |
Free Cash Flow Range, Past 5 Years
-46.87M
Minimum
Sep 2022
11.59M
Maximum
Sep 2023
-22.47M
Average
-24.93M
Median
Mar 2020
Free Cash Flow Benchmarks
| Matinas BioPharma Holdings Inc | -17.87M |
| Tenon Medical Inc | -10.46M |
| Alphatec Holdings Inc | -197.78M |
| Madrigal Pharmaceuticals Inc | -438.32M |
| Spero Therapeutics Inc | -14.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.73M |
| Cash from Investing (Quarterly) | -1.351M |
| Cash from Financing (Quarterly) | 0.091M |
| Free Cash Flow Per Share (Quarterly) | 0.0183 |
| Free Cash Flow to Equity (Quarterly) | 0.668M |
| Free Cash Flow to Firm (Quarterly) | 0.668M |
| Free Cash Flow Yield | -65.00% |